Unipharm Global, known as Unipharm, is a company with over 45 years of experience in excelling at generic research and development (R&D) and production. The company provides timely, responsive support to its customers in an agile, flexible, and reliable manner, fulfilling their every need and expectation. Unipharm's dedication to its customers is reflected in its entrepreneurial culture which enables fast action and responsive solutions to customer needs, efficient project planning, and swift management decision-making.

Unipharm specializes in out-licensing projects and ensures a swift registration process leading to a successful product launch. The company markets a broad range of niche generics, including products for which only a few manufacturers remain worldwide, thereby offering unique opportunities for global customers.

Unipharm showcases flexibility by shortening delivery times, providing quantities beyond forecasts, and responding to specific customer requests. Their large generic portfolio covers various therapeutic areas such as cardiovascular, central nervous system, anti-infectives, men’s health, musculoskeletal, gastro, and ophthalmics.

The company operates in numerous countries, possesses an EU-Recognized GMP Manufacturing area, and maintains a substantial catalog of generic products.